CD38 and acute myeloid leukemia: Herrmann et al. (32) described the overexpression of BRD4 in AML patient samples, even in highly enriched CD34+/CD38− and CD34+/CD38+ stem and progenitor cells and showed that JQ1 was capable of inducing the apoptosis of these cells.